Jounce Therapeutics Inc. (JNCE) Gained 11.72% or 0.4 To Price $3.77 On Wednesday


Jounce Therapeutics Inc. (JNCE) gained 11.72% or 0.4 to $3.77. It is around 143013 shares traded, which is 38.18% compare to the average total volume 374581. The market cap of JNCE is $123.12 million. The year to date change is -63.13%. The 52 week price range is from $2.66 to $29.25. Price of JNCE have changed 25.28% during last week. It have changed -24.61% over last month, -48.15% over last 3 months, -55.31% over last 6 months and -74.18% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 4.35. It is 15.38% above current price. The 200-day Moving Averages for JNCE is 10.00. It is 165.25% above current price. The 52-week High is 29.25. It is 675.86% from the current price. The 52-week Low is 2.66. It is -29.44% from current price.

There are some statistics of JNCE. It is has market cap $123.12 million. The share outstanding is 32.70 million. The average volume is 374581. The percent of top 15 Institution holding is 105.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -24.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -12.59%.


Tags:

Share this post